Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5857 posts found.

top_10_image_43

Top Ten most popular articles on Pharmafile.com this week

January 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019, compared …
News
roche__tree

EU approval for Roche’s Polivy combo in relapsed/refractory B-cell lymphoma

January 21, 2020 Manufacturing and Production, Sales and Marketing Cancer, Polivy, Roche, lymphoma, pharma

The European Commission has awarded conditional marketing approval to Roche’s Polivy (polatuzumab vedotin), it has been revealed.
News

Janssen’s ulcerative colitis medicine not recommended by NICE for use in adults

January 21, 2020 Manufacturing and Production IBS, Irrated Bowels, NHS, NICE, bowel, ulcerative colitis

NICE has published draft guidance which does not recommend Stelara (ustekinumab) for treating moderately to severely active ulcerative colitis in …
News
jazz_pharma

Jazz Pharma’s Sunosi becomes first EU-approved drug of its kind in narcolepsy and sleep apnoea

January 21, 2020 Manufacturing and Production, Sales and Marketing jazz pharmaceuticals, narcolepsy, pharma

Jazz Pharmaceuticals has secured approval from the European Commission for Sunosi (solriamfetol), it has emerged, as a therapy to improve …
News
29419203133_3c3c14e63e_z

Cardiff University team discovers new method of killing cancers

January 21, 2020 Manufacturing and Production Cancer, Cancer cures, Cancerous, Cardiff University, T cell, cells, immune system, immunity, t-cell

A team at Cardiff University have discovered a new part of the human immune system that could be harnessed to …
News

Novartis’ Mayzent granted license by the European Medicines Agency

January 21, 2020 Manufacturing and Production CNS, European Medicines Agency, NHS, NICE, Novartis

The European Medicines Agency (EMA) has granted a licence for the use of Mayzent (siponimod) in the treatment of certain …
News
gettyimages-952692342-5c16809146e0fb0001dee456

Collaborating to realise the potential of precision medicine

January 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Precision Medicine, feature, pharma

Healthcare is an evolving continuum, and while traditional strategies have seen improvements to patient outcomes over time, voices in the …
Feature
steven_hildemann

Ipsen appoints new Exec VP and Chief Medical Officer

January 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma

Ipsen has named Dr Steven Hildemann as its new Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs …
Appointment
4420456374_64a3d7e6aa_88_2

Top Ten most popular articles on Pharmafile.com this week

January 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, European Commission, FDA, Pakistan, Sanofi, Teva

Pakistan is cracking down on corruption and has registered cases against 200 pharmaceutical companies, while in the US the FDA …
News
6934974672_fd18b2ea20_b

Chinese coronavirus found in Thailand

January 14, 2020 Manufacturing and Production China, WHO, World Health Organisation, Wuhan, pneumonia, thailand

The recent viral pneumonia outbreak in Wuhan China has spread to Thailand.The patient is a 61 year old woman who …
News
shutterstock_512649

MorphoSys and Incyte forge potential $1.1bn partnership to develop B cell malignancy drug candidate

January 14, 2020 Manufacturing and Production, Sales and Marketing Incyte, morphosys, pharma, tafasitamab

MorphoSys and Incyte have joined together in a partnership to develop and commercialise the latter’s anti-CD19 antibody tafasitamab as a …
News
business-laptop-computer-money

Acasti’s shares plunge as new drug does not meet primary endpoint

January 14, 2020 Manufacturing and Production Acasti, Acasti Pharma, CaPre, Primary Endpoint, Shares

Acasti Pharma’s shares plunged by as much as 67% this week as its drug CaPre failed to meet its primary …
News
biogen_austria_238

Biogen picks up Pfizer’s Phase 1 therapy for Alzheimer’s symptoms in potential $700m deal

January 14, 2020 Manufacturing and Production, Sales and Marketing Alzheimer's, Biogen, Pfizer, pharma

Biogen has entered into an agreement with Pfizer to acquire the latter’s Phase 1 candidate PF-05251749 in order to develop …
News
nhs_old_hospital_1

NHS to pioneer Novartis injection that reduces cholesterol

January 14, 2020 Manufacturing and Production NHS, NHS England, bad cholesterol, cholesterol, heart attack

The NHS in England is pioneering a new twice-a-year injection, inclisiran, which reduces bad cholesterol.It has reached a deal with …
News
jp-kress_mor

Working Life Interview: Jean-Paul Kress, CEO of MorphoSys

January 13, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Working Life, feature, morphosys, pharma

With a medical doctorate as well as degrees in pharmacology and immunology under your belt, was your path always to …
Feature
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026